Drug recall D-0230-2026

Class II Ongoing reported Dec 24, 2025

Product

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

Reason for recall

Defective container: cracked/broken cartridges

Lots and codes

Lot: D05159C, expires: 07-31-2027

Recall details

Recalling firm
Novocol Pharmaceutical of Canada, Inc., Cambridge
Quantity
5,825
Distribution
U.S.A. Nationwide
Type
Voluntary: Firm initiated
Recall initiated
October 31, 2025

Related products